🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Betw...
Status
Unknown
Location
Lexicon Investigational Site
Start Date
2015-07
Trial ID
NCT02494609
Treatments Being Tested
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Start Date
2023-11-13
Trial ID
NCT05870579
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-01
Trial ID
NCT04337658
Treatments Being Tested
During an In Vitro Fertilization (IVF) attempt, several embryos are obtaine...
Status
Completed
Location
CHU Toulouse
Start Date
2021-12-07
Trial ID
NCT05109676
Treatments Being Tested
The present study is set up to evaluate the efficacy of a programmation by ...
Status
Completed
Location
UZ Brussel, Centre for Reproductive Medicine
Start Date
2010-05
Trial ID
NCT01218386
Treatments Being Tested
SAFIR PI3K is an open-label multicenter phase II randomized trial, comparin...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2018-03-15
Trial ID
NCT03386162
Treatments Being Tested
The purpose of this study is to assess the bioequivalence of the contracept...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01535820
This is a multi-center, observational study designed to explore the regulat...
Status
Unknown
Location
Cancer Hospital, ChineseAMS
Start Date
2019-02-14
Trial ID
NCT04289974
Treatments Being Tested
A randomized, double-blind, multicenter phase III clinical study to evaluat...
Status
Not Yet Recruiting
Location
Clinical Trials Information Group
Start Date
2025-04
Trial ID
NCT06929325